Atlas Trials

Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma

Clinical trial NCT02027220 · UNKNOWN

Trial details

NCT number
NCT02027220
Sponsor
Second Affiliated Hospital of Soochow University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
MyelomaBortezomibCyclophosphamideDexamethasoneGranulocyte Colony-Stimulating Factor
Start date
2013-12-01
Primary completion
2015-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.